5 completed, 1 not yet recruiting, 1 recruiting. 7 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 5, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 3 | Completed 2, Recruiting 1 |
Follow Mental Disorder: new trials by email Literature Review of Mental Disorder trials Research Report on Mental Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Virtual Menstrual Pain Approaches in Females Virtual Auricular Acupressure, Virtual Baduanjin Qigong Exercise, Self Education - Pain (Visceral, Somatic, or Neuropathic), Women of Reproductive Age | Phase 2 / Phase 3 | Recruiting | Nanyang Technological University | 145 | 2026-04-15 | 2026-06-23 |
| Evaluation of the Efficacy of Immunomodulatory Therapy in Case of Psychiatric Disorders With Proven Dysimmunity. immunomodulatory treatment by rituximab - Mental Disorder | Phase 3 | Not yet recruiting | University Hospital, Bordeaux | 174 | 2023-10-15 | 2023-07-14 |
| Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Brexpiprazole, OPC-34712 - Agitation Associated With, Alzheimer's Disease | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 270 | 2013-09-01 | 2020-11-20 |
| A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation Brexpiprazole, OPC-34712, Placebo Oral Tablet - Agitation Associated With, Alzheimer's Disease | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 433 | 2013-07-11 | 2020-12-31 |
| Homeopathic Medication and Nutritional Oriented Diet to Treat Overweight Pregnant Women With Mental Disorder Sulph, Puls, Lyc, Lack t, Con, Sep, Nux v, Calc c, Phos, Homeopathy and Nutritional oriented diet - Overweight, Pregnancy | Phase 2 / Phase 3 | Completed | Edgard Costa de Vilhena | 134 | 2009-08-01 | 2013-05-13 |
| A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001) Esmirtazapine - Sleep Initiation and Maintenance Disorder; Elderly, Mental Disorder | Phase 3 | Completed | Merck Sharp & Dohme LLC | 259 | 2008-01-09 | 2021-01-27 |
| 15 Year Follow-up of New Beginnings Program for Divorced Families New Beginnings Program - Mental Disorder, Substance Use | Phase 2 / Phase 3 | Completed | Arizona State University | 240 | 2006-07-01 | 2011-08-02 |
Mental Disorders (7) · Alzheimer Disease (2) · Cognitive Dysfunction (2) · Dementia (2) · Nervous System Diseases (2) · Psychomotor Agitation (2) · Dyssomnias (1) · Obesity (1) · Overweight (1) · Pain (1) · Psychotic Disorders (1) · Sleep Disorders, Intrinsic (1) · Sleep Wake Disorders (1) · Substance-Related Disorders (1)
Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Neurologic Manifestations (4) · Aberrant Motor Behavior in Dementia (2) · Behavior (2) · Behavioral Symptoms (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Cognition Disorders (2) · Dyskinesias (2) · Neurobehavioral Manifestations (2) · Neurocognitive Disorders (2) · Neurodegenerative Diseases (2) · Psychomotor Disorders (2) · Tauopathies (2)
brexpiprazole (2) · Homeopathy (1) · Mirtazapine (1) · Phosphorus (1) · Phosphorus, Dietary (1) · Selenoprotein P (1) · Sulfur (1)
Otsuka Pharmaceutical Development & Commercialization, Inc. (2) · Arizona State University (1) · Edgard Costa de Vilhena (1) · Merck Sharp & Dohme LLC (1) · Nanyang Technological University (1) · University Hospital, Bordeaux (1)
United States (3) · France (2) · Russia (2) · Ukraine (2) · Brazil (1) · Bulgaria (1) · Canada (1) · Croatia (1) · Finland (1) · Germany (1) · Serbia (1) · Singapore (1) · Slovenia (1) · Spain (1) · United Kingdom (1)
Edgard C Vilhena, MD (1) · Eva Kohegyi, MD (1) · Eva Koheygi, MD (1) · Sharlene A Wolchik, Ph.D. (1)
PMID 31708380, PMID 39108660, PMID 40681915, PMID 41533472, PMID 41591746, PMID 41961243, PMID 23750466, PMID 24484456, PMID 25367835, PMID 25382415, PMID 26465217, PMID 26692236, PMID 40847656, PMID 41439450, PMID 41689409, PMID 42052145, PMID 42502037
P30MH068685 (1)